|
Roche Diagnostics Captures Largest Number of Frost & Sullivan's
2002 Excellence in Healthcare Awards
SAN JOSE, Calif. - November 7, 2002 - Frost & Sullivan honored
Roche Diagnostics Corporation and its President and CEO, Martin
Madaus, with the presentation of three prominent awards at last
night's 2002 Excellence in Healthcare Awards Banquet held in La
Jolla, California.
Frost & Sullivan bestowed the Clinical Diagnostics Company
of the Year and Market Engineering Leadership awards to Roche Diagnostics
and Clinical Diagnostics CEO of the Year to Mr. Madaus. In addition
to accepting the awards at the banquet, Mr. Madaus delivered the
Keynote Speech, regarding leading innovation in global healthcare
companies.
The Company of the Year award recognizes the company that Frost
and Sullivan deems to have demonstrated unparalleled excellence
in its industry and is perceived to exhibit outstanding management
and consistent growth, as well as a positive social and economic
impact on local and national communities.
"Roche Diagnostics exhibits strong growth in the clinical
diagnostics industry- maintaining an impressive lead in this dynamic
market. Roche is one of the first clinical diagnostic companies
to employ direct-to-consumer marketing, a bold move that promises
to further augment and establish their market presence," explains
Frost & Sullivan Industry Analyst Kelly Westfall, MT. "Additionally,
Roche has recently secured substantial contracts with GPOs and is
currently at the vanguard of molecular diagnostics innovation. Successful
marketing and innovation in this comprehensive smoothly run business
unit is largely responsible for Roche Diagnostics' unmatched excellence.
Frost & Sullivan's Market Engineering Leadership award is presented
to the company that has exhibited market share leadership in its
industry and the ability to monitor market changes and implement
successful strategies to address these dynamics.
Roche leads by more than forty-one percent when comparing its annual
revenues to those of its closest competitor. Roche, the most prolific
of all clinical diagnostic companies, continues to direct the market
with highly innovative products and health solutions.
The CEO of the Year award acknowledges the CEO who has best demonstrated
leadership excellence within his industry. Performance measurement
has been based on decisions that improved earnings and market standing,
as well as vision and risk-taking.
Since his appointment as President and CEO in January 2000, Mr.
Madaus leads Roche Diagnostics to product innovation and production
before other companies achieve the same technology and applications.
Mr. Madaus also places strong emphasis on customer satisfaction,
which remains high for Roche, as well as the talents of his people,
whom he recognizes as largely responsible for the continued success
of the company.
"The Frost and Sullivan awards are an honor because they are
a testimony to our innovative and talented people." said Martin
Madaus, President and CEO of Roche Diagnostics, North America. "Our
culture and commitment developing actionable health information
drives us to do our very best and these awards are an inspiration
for us to keep changing and innovating our industry ".
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading research-oriented healthcare groups. The company's two core
businesses in pharmaceuticals and diagnostics provide innovative
products and services, that address prevention, diagnosis and treatment
of diseases, thus enhancing people's health and quality of life.
The two core businesses achieved a turnover of 13,1 billion Swiss
Francs in the 1st half of 2002 and employed about 57,000 employees
worldwide. Roche's Diagnostics Division, the world leader in in-vitro
diagnostics with a uniquely broad product portfolio, supplies a
wide array of innovative testing products and services to researchers,
physicians, patients, hospitals and laboratories world-wide. Its
North American headquarters are located in Indianapolis, Ind. For
further information, visit www.roche.com
and www.roche-diagnostics.com.
About Frost & Sullivan
Founded in 1961, Frost & Sullivan, a global leader in strategic
market training and growth consulting, presents Market Engineering
Awards to companies that demonstrate excellence in their industry,
commending the innovative business strategies required to advance
in the global marketplace. Frost & Sullivan rigorously analyzes
specific criteria to determine Market Engineering Award recipients
in a vast variety of market industries and landscapes. For further
information, visit www.frost.com.
|